Aurinia Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.

About AUPH

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

CEO

Kevin C. Tang

CEOKevin C. Tang

Employees

128

Employees128

Headquarters

Edmonton, Alberta

HeadquartersEdmonton, Alberta

Founded

1993

Founded1993

Employees

128

Employees128

AUPH Key Statistics

Market cap

2.01B

Market cap2.01B

Price-Earnings ratio

7.32

Price-Earnings ratio7.32

Dividend yield

—

Dividend yield—

Average volume

1.43M

Average volume1.43M

High today

$16.17

High today$16.17

Low today

$15.58

Low today$15.58

Open price

$16.06

Open price$16.06

Volume

783.62K

Volume783.62K

52 Week high

$16.88

52 Week high$16.88

52 Week low

$7.29

52 Week low$7.29

Stock Snapshot

The current Aurinia Pharmaceuticals(AUPH) stock price is $15.60, with a market capitalization of 2.01B. The stock trades at a price-to-earnings (P/E) ratio of 7.32.

On 2026-06-08, Aurinia Pharmaceuticals(AUPH) stock moved within a range of $15.58 to $16.17. With shares now at $15.60, the stock is trading +0.1% above its intraday low and -3.5% below the session's peak.

Trading volume for Aurinia Pharmaceuticals(AUPH) stock has reached 783.62K, versus its average volume of 1.43M.

The stock's 52-week range extends from a low of $7.29 to a high of $16.88.

AUPH News

Nasdaq 2d

Aurinia Pharmaceuticals' CEO Bought 815,000 Shares for $12.5 Million

Key Points 814,606 common shares acquired for a total transaction value of approximately $12.5 million, based on a weighted average price of $15.29 per share....

TipRanks 4d

Aurinia Shareholders Back Board Slate and Governance Measures

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

TipRanks 5d

Aurinia Pharmaceuticals up 4% in pre-market after insider transactions

Last night, the company stated: “Tang Capital Management announces that on June 2, 2026, it acquired 206,005 common shares of Aurinia Pharmaceuticals (AUPH) at...

Analyst ratings

57%

of 7 ratings

Buy

42.9%

Hold

57.1%

Sell

People also own

Based on the portfolios of people who own AUPH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.